Delivery Order SPE2DB24D8002-SPE2DB25FJMPU
Award Date
10/28/24
Potential Completion Date
10/29/24
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,317.13, is for the delivery of the pharmaceutical product Fluticasone-Salmeterol 115-21 12GM. The contract has an ultimate completion date of February 25, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, SPE2DB24D8001, valued at $999,999,999.00, as...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product, with a ceiling value of $9,035.88 and a period of performance through March 3, 2025. The contract is not set aside. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as...
This is a $6,331.52 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product, with a performance period ending on January 15, 2025. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the ECAT Generation V Program, which allows the company to...
This federal contract award, valued at $3,405.30, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of fluticasone-salmeterol 115-21 12GM pharmaceutical products, which are likely used for respiratory conditions. The contract has an ultimate completion date of April 10, 2025 and is a firm fixed-price delivery order. Dakota Drug, Inc. has a significant single-award Indefinite Delivery Contract...
This is a $1,479.28 Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the delivery of FLUTICASONE-SALMETEROL 115-21 12GM, a respiratory medication, with a period of performance through June 12, 2025. Dakota Drug, Inc. also holds a large Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of the pharmaceutical product Fluticasone-Salmeterol 115-21 12GM. The contract has a ceiling value of $8,385.19 and an ultimate completion date of March 26, 2024. There is no set-aside designation for this award. Dakota Drug, Inc. has over two decades of experience as a prime contractor to the federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the supply of fluticasone-salmeterol 45-21 12GM, a pharmaceutical product, with a ceiling value of $2,565.56 and a performance period ending on May 23, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. Dakota Drug, Inc. holds a significant single-award Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of the pharmaceutical product "FLUTICASONE-SALMETEROL 115-21 12GM". The contract has a potential value of $11,906.17 and a completion date of February 21, 2024. Dakota Drug, Inc. is an experienced federal contractor, having served as a prime to the DLA Troop Support Medical for over two...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,553.05, is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a respiratory medication, to support U.S. Armed Forces medical operations. The contract is a firm fixed-price, non-set-aside award with a completion date of January 28, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract...
This is a $4,303.40 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the supply of FLUTICASONE-SALMETEROL 230-21 12GM, a pharmaceutical product, with a performance period ending on January 31, 2024. This award does not utilize any set-aside designation. As a prime contractor with over two decades of experience serving the Department of Defense and...